The purpose of the Flow Cytometry and Functional Immunology Research Core is to provide a centralized resource of technical expertise and major equipment to support and enhance the experimental design and execution of basic and clinical research in HIV pathogenesis that require application of flow cytometric phenotypic analysis, cell sorting, and/or evaluation of specific immune cell functions. A prime goal is to provide the intellectual environment and the material resources to enable junior investigators to apply flow cytometry technology to their projects and to encourage established investigators to initiate innovative pilot studies. To achieve these objectives, expert consultation is provided through the Core Director, Associate Directors, and technical supervisor;major instruments are selected for complementary functions; equipment use is accessible through dedicated technician operators;services are provided on a recharge basis;generated data are analyzed, reduced, and diagramed;and fiscal support is given to pilot and exploratory research projects through the provision of research reagents and instrument time. CFAR resources have enabled the Core to support a wide array of HIV research encompassing basic projects on viral regulation and mechanisms of pathogenesis to preclinical development of vaccines and gene therapies, and clinical studies of primary infection, opportunistic infections, neurobiology, and immune and viral responses to vaccines and HAART. To maintain our flow cytometry facility to meet the needs of the San Diego academic research community, several funding sources have been integrated for cooperative support: the UCSD Center for AIDS Research (CFAR), the VA Research Center for AIDS and HIV Infection (RCAHI), and the Veterans Affairs Medical Research Foundation (VMRF). In addition to principal investigators based at UCSD and the VA Medical Center, investigators from The Scripps Research Institute, the Salk Institute, the La Jolla Institute of Allergy and Immunology, and the Burnham Institute also utilize the resources provided by our central facility. Local use of flow cytometric technology continues to grow and diversify, and the Core facility strives to keep up with the growing demand. The CFAR award remains an integral component in this endeavor. Application of flow cytometry to several areas of biomolecular research, in addition to expanded applications in clinical research, makes continued CFAR support crucial to providing the infrastructure to take advantage of new scientific opportunities in HIV research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI036214-18S1
Application #
8440961
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
2013-03-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
18
Fiscal Year
2012
Total Cost
$169,350
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :
Stone, Jack; Fraser, Hannah; Lim, Aaron G et al. (2018) Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 18:1397-1409

Showing the most recent 10 out of 921 publications